Zobrazeno 1 - 10 of 51 pro vyhledávání: '"Orly Eizenberg"'
1
Akademický článek
Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte Recruitment
Autor: Shira Hagbi-Levi, Michal Abraham, Liran Tiosano, Batya Rinsky, Michelle Grunin, Orly Eizenberg, Amnon Peled, Itay Chowers
Publikováno v: Journal of Immunology Research, Vol 2019 (2019)
Background. Age-related macular degeneration (AMD), the most common cause of blindness in the developed world, usually affects individuals older than 60 years of age. The majority of visual loss in this disease is attributable to the development of c
Externí odkaz: https://doaj.org/article/f194585487bd4e4d8954864b07762856
Zobrazit plný text záznamu
2
Akademický článek
Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation
Autor: Michal Abraham, Hanna Wald, Dalit Vaizel-Ohayon, Valentin Grabovsky, Zohar Oren, Arnon Karni, Lola Weiss, Eithan Galun, Amnon Peled, Orly Eizenberg
Publikováno v: Frontiers in Immunology, Vol 8 (2017)
Chemokines and their receptors play critical roles in the progression of autoimmunity and inflammation. Typically, multiple chemokines are involved in the development of these pathologies. Indeed, targeting single chemokines or chemokine receptors ha
Externí odkaz: https://doaj.org/article/54ac62089aa547c4a8b5e81b330de3d4
Zobrazit plný text záznamu
5
Data from Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML In Vitro and In Vivo
Autor: Arnon Nagler, Amnon Peled, Orly Eizenberg, Eithan Galun, Ori Wald, Hanna Wald, Michal Abraham, Maya Koren-Michowitz, Orly Blaier, Merav Darash-Yahana, Katia Beider
Functional role of CXCR4 in chronic myelogenous leukemia (CML) progression was evaluated. Elevated CXCR4 significantly increased the in vitro survival and proliferation in response to CXCL12. CXCR4 stimulation resulted in activation of extracellular
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9edca01f214dba541b8cf90406fcb3fd
https://doi.org/10.1158/1535-7163.c.6536275
Zobrazit plný text záznamu
10
Data from Targeting the CD20 and CXCR4 Pathways in Non-Hodgkin Lymphoma with Rituximab and High-Affinity CXCR4 Antagonist BKT140
Autor: Arnon Nagler, Amnon Peled, Orly Eizenberg, Abraham Avigdor, Eithan Galun, Evgenia Rosenberg, Lola Weiss, Hanna Wald, Michal Abraham, Elena Ribakovsky, Katia Beider
Purpose: Chemokine axis CXCR4/CXCL12 is critically involved in the survival and trafficking of normal and malignant B lymphocytes. Here, we investigated the effect of high-affinity CXCR4 antagonist BKT140 on lymphoma cell growth and rituximab-induced
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3af8615db601693cc6369ace446e772
https://doi.org/10.1158/1078-0432.c.6522306
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje